Abstract
Organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDGEORTC), Trends in Medical Mycology (TIMM) has be-come the essential global forum to discuss the most important advances and research find-ings in mycology from basic science to clinical and laboratory research. TIMM-7 was the seventh of this series of biennial international meetings for physicians and scientists with interests in medical mycology. Delegates heard expert presentations on a range of topics, but antifungal drug resistance was a key concern for the meeting in light of the threat posed to the health and survival of seriously ill, immunocompromized patients.
Keywords: Invasive fungal infections, resistance, candida, aspergillus.
Graphical Abstract
Anti-Infective Agents
Title:Facing the threat of Antifungal Resistance: Report from the 7th Trends in Medical Mycology (TIMM-7) 9-12 October 2015, Lisbon, Portugal
Volume: 14 Issue: 2
Author(s): Sue Lyon
Affiliation:
Keywords: Invasive fungal infections, resistance, candida, aspergillus.
Abstract: Organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDGEORTC), Trends in Medical Mycology (TIMM) has be-come the essential global forum to discuss the most important advances and research find-ings in mycology from basic science to clinical and laboratory research. TIMM-7 was the seventh of this series of biennial international meetings for physicians and scientists with interests in medical mycology. Delegates heard expert presentations on a range of topics, but antifungal drug resistance was a key concern for the meeting in light of the threat posed to the health and survival of seriously ill, immunocompromized patients.
Export Options
About this article
Cite this article as:
Lyon Sue, Facing the threat of Antifungal Resistance: Report from the 7th Trends in Medical Mycology (TIMM-7) 9-12 October 2015, Lisbon, Portugal, Anti-Infective Agents 2016; 14 (2) . https://dx.doi.org/10.2174/2211352514666160819162110
DOI https://dx.doi.org/10.2174/2211352514666160819162110 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Potential of 11C-acetate PET for Monitoring the Fatty Acid Synthesis Pathway in Tumors
Current Pharmaceutical Biotechnology Targeted Strategies in the Treatment of Primary Gastric Lymphomas: From Rituximab to Recent Insights into Potential New Drugs
Current Medicinal Chemistry Delivery Systems of Opioid Analgesics for Pain Relief: A Review
Current Pharmaceutical Design Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature
Reviews on Recent Clinical Trials The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management
Recent Patents on Anti-Infective Drug Discovery Enhancing Oral Bioavailability of Methylnaltrexone Using an Emulsion Formulation
Letters in Drug Design & Discovery Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Seeds of Mung Bean (<i>Vigna radiata</i> (L.) R.Wilczek): Taxonomy, Phytochemistry, Medicinal Uses and Pharmacology
Current Bioactive Compounds Stem Cells in Cardiovascular Regeneration: From Preservation of Endogenous Repair to Future Cardiovascular Therapies
Current Pharmaceutical Design Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine IL-2 Receptor Targeted Immunomodulatory Biologics: The Past, Present, and Future
Current Immunology Reviews (Discontinued) Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions
Current Pharmaceutical Design Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy
Current Cancer Therapy Reviews HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?
Current Cancer Drug Targets Bergamot Juice Extract Inhibits Proliferation by Inducing Apoptosis in Human Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Substrate Specificity, Regulation, and Polymorphism of Human Cytochrome P450 2B6
Current Drug Metabolism Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine The Roles of Vitamin D and Its Analogs in Inflammatory Diseases
Current Topics in Medicinal Chemistry Single Nucleotide Polymorphisms (SNPs): History, Biotechnological Outlook and Practical Applications
Current Pharmacogenomics